All In MedTech

Company

Novocure

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

NVCR

Nasdaq · NovoCure Ltd

Public float

$995M

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$655M

Fiscal year ending Dec 31, 2025

Net income

-$136M

Fiscal year ending Dec 31, 2025

R&D spending

$225M

Fiscal year ending Dec 31, 2025

Cash

$96.7M

As of Sep 30, 2026

Long-term debt

$195M

As of Dec 31, 2025

Shares outstanding

116.9M

As of Oct 23, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2025–$3.7M$100.0M–
2024–$4.2M$96.9M–
2023–$4.4M––
2022–$5.2M––
2021–$4.5M––

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For Novocure we have 3 shareholders with 5% or more.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

Search the Clearance Tracker

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

24 more trials with a free account

Reports received

282

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

0

0.0% of reports

Injury reports

280

99% of reports

Death reports

2

0.7% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230100
Jan 240400
Feb 240400
Mar 240500
Apr 240700
May 240800
Jun 2401300
Jul 2401500
Aug 2402300
Sep 2401600
Oct 2402200
Nov 2402000
Dec 2402100
Jan 2502000
Feb 2501900
Mar 2502300
Apr 2512600
May 2501900
Jun 2502000
Jul 2502000
Aug 2501900
Sep 2501300
Oct 2502500
Nov 2501700
Dec 2503300
Jan 2601300
Feb 2601700
Mar 2602000
Apr 2601100
May 2602300
Jun 2604210
Jul 2602800
Aug 2602200
Sep 2603110
Oct 2602300
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

1 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

2 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recalls under this name in FDA's data.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.